![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces First Quarter 2009 Results Conference Call
April 28, 2009 10:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 28, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Presents New Preclinical Data From Its Heat Shock Protein 90 Inhibitor Program At AACR
April 21, 2009 15:00 ET
|
Infinity Pharmaceuticals, Inc.
DENVER, Colo. and CAMBRIDGE, Mass., April 21, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today presented data from its heat shock protein 90 (Hsp90) inhibitor program that...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Presents Preclinical Data Demonstrating Potential of Hedgehog Pathway Inhibition With IPI-926 in Multiple Cancer Settings
April 21, 2009 10:00 ET
|
Infinity Pharmaceuticals, Inc.
DENVER and CAMBRIDGE, Mass., April 21, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today presented preclinical data from studies of IPI-926, its oral Hedgehog pathway...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Halts RING Trial in Advanced Gastrointestinal Stromal Tumors
April 15, 2009 09:15 ET
|
Infinity Pharmaceuticals, Inc.
-- Decision Based On Recommendation Received Tuesday Night From
Independent Data Monitoring Committee --
-- Infinity Reaffirms Commitment to Hsp90 Development and Cash
...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present Preclinical Data From Its Hsp90 Inhibitor Program and Its Hedgehog Signaling Pathway Inhibitor Program At AACR Meeting
April 08, 2009 06:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 8, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it will be reporting...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Leadership Promotions
April 07, 2009 06:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 7, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced two leadership...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Initiates International Phase 2 Trial of IPI-504 in Combination With Herceptin(r) in Patients With HER2-Positive Breast Cancer
March 30, 2009 06:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 30, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the initiation of a...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Presents the Chemistry and Discovery of IPI-926, Its Novel Hedgehog Signaling Pathway Inhibitor, At ACS Meeting
March 25, 2009 11:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass. and SALT LAKE CITY, March 25, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced data...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present At the Future Leaders Conference
March 23, 2009 07:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 23, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present the Discovery of IPI-926, Its Hedgehog Signaling Pathway Inhibitor, At ACS Meeting
March 17, 2009 07:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 17, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it will be...